NCT03428217 · Interventional trial
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Overall registry status Completed
Phase 2
Conditions Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory